[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"tacs\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:tacs":41},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":5},"100490306","using-transcranial-alternating-current-stimulation-to-improve-executive-function-in-22q112-deletion-syndrome-100490306",false,"NCT05664412","Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome","Using Transcranial Alternating Current Stimulation With Starstim Home Device to Improve Executive Function in Youths With 22q11.2 Deletion Syndrome: A Randomized Double-blind Sham-controlled Study","Inclusion Criteria:\n\n* Confirmed genetic diagnosis of 22q11DS\n* Age between 14 and 25 years old\n* Willingness to participate\n* Informed Consent signed by the subject and\u002For the caregiver(s)\n\nExclusion Criteria:\n\n* Epilepsy\n* Deep brain stimulation electrodes\n* Traumatic brain injury\n* Facial metal implants","ALL","14 Years","25 Years",{"count":20,"type":21},40,"ESTIMATED","INTERVENTIONAL",[24],"NA","The purpose of this project is to explore the effects of transcranial alternating current stimulation (tACS) in children, adolescents and young adults with a 22q11.2 microdeletion. The main aim of the present research project is to investigate the effects of repeated, individually tuned high-density (HD) tACS on cognition (i.e., WM performance) and related neuroimaging markers in carriers of the 22q11DS. As cognitive deficits, most notably WM impairment, are among the earliest signs of psychotic disorders, interventions during adolescence aimed at reducing cognitive decline in at-risk individuals may prove effective in delaying or even preventing the later emergence of psychotic symptoms.",[27,28],"22Q11 Deletion Syndrome","tACS","RECRUITING","2025-12-01",{"date":32,"type":33},"2025-12-02","ACTUAL",{"date":35,"type":33},"2023-10-20",{"date":37,"type":21},"2026-12-31",{"name":39,"class":40},"Stephan Eliez","OTHER","TACS"]